Clinical Trial

A Non-interventional Registry for Patients with Hepatitis B Virus Infection

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated March 13, 2025 (before its estimated December 2025 completion). Its status may not reflect the trial's current state.
Summary
In order to tackle the unmet needs in chronic HBV infection, a consortium of clinical partners has gathered to establish a registry for patients with hepatitis B mono- and co-infections. The partners will build up a European-wide registry to be able to stratify patients for upcoming clinical trials. Extensive analyses of virus and host-specific parameters are to be carried out from these patients. The knowledge gained thereby should contribute to a better understanding of the HBV control and enable patient stratification with regard to immunomodulatory therapies. Furthermore, hepatitis B patients are to be identified who are willing to participate in future studies to investigate immunotherapies to cure HBV infections (e.g. therapeutic vaccines).
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2021-09-20; most recent amendment 2025-03-11.
Trial Details
NCT Number NCT05051098
Lead Sponsor Hannover Medical School
Collaborators: European Union, German Center for Infection Research, German Liver Foundation (DLS)
Conditions Hepatitis B Virus Infection
Enrollment 3,000 participants
Start Date 2021-05-06
Primary Completion 2025-12 (estimated)
Study Completion 2025-12 (estimated)
Updated on ClinicalTrials.gov 2025-03-13